Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Total 13F shares
-
1,795,515
-
Share change
-
-143,522
-
Total reported value
-
$15,261,000
-
Price per share
-
$8.50
-
Number of holders
-
9
-
Value change
-
-$1,244,081
-
Number of buys
-
4
-
Number of sells
-
9
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q1 2022
As of 31 Mar 2022,
Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,795,515 shares.
The largest 9 holders included
COMPASS GROUP LLC, Itau Unibanco Holding S.A., SECTORAL ASSET MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, Penserra Capital Management LLC, MORGAN STANLEY, and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.